Post
by duncan » Sun 15 Feb 2015 14:05
If it weren't for the silly contrived PTLDS label, many of us who do not quite qualify under the 2T system would be slapped with the ME/CFS label. In fact, technically, PTLDS is ME/CFS in a lot of main street medicine's eyes. Of course, many who never met the 2T requirements are, or were, thrust into a ME/CFS diagnosis at one time or another, myself included.
It is commonly believed that there is a trigger mechanism for ME/CFS. EBV as the principal agent behind the disorder was a highly popular theory. Today, it is believed it could be ANY trigger - including Bb - that for some unknown reason sends our bodies' major systems spiraling out of control.
One controversial unifying theory was/is a retroviral connection. Most of us are familiar with the XMRV saga. But even after XMRV, Lipkin (Columbia U) and Montoya (Stanford?) found a retrovirus in 85% of ME/CFSers examined. Lipkin discounted that, though, because they also found that retrovirus in controls. But if it were an endogenous retrovirus that was somehow triggered from latency or harmless inactivity into something more pathogenic...But, eh, that has not been demonstrated. In fact, no single pathogen has been proven across the patient population, although many have been suggested, and a few seem to hold true for parts of the population , including enteroviruses and herpes viruses.
What does all that mean? It means that the hunt for a pathogen SHOULD be on in earnest, and be endorsed and financed by government agencies.
Only, it isn't, at least not in any substantive fashion.
Same holds true with PTLDS. If you look real hard at who is studying Lyme patients who remain sick AFTER treatment, you won't find a lot of researchers with backing. And in that group I'm including individuals or agiencies - including the NIH - studying 2T positive folk. So, if it is NOT Bb keeping us sick, what is it? Broken autoimmune systems? Okay...but demonstrate that already and quit screwing around.
Back to ME/CFS, or SEID: A major hit the new IOM report took is the emphasis it placed on SYMPTOMS vs overt and measurable biological components and pathways. Detractors are concerned that the name change is much ado about nothing because it's still pretty much a shell game that pivots around self-reported symptoms... That it will not result in demands - demands that cannot be ignored because of acknowledged studies - that more monies be dedicated to researching the proven biologies already on the table. There are lots of studies out there demonstrating immune dysfunction - Ig class dysregulation, for example. Where is all the money with which to launch a full scale investigation? Where is even the dollars for replication efforts toward pre-existing studies? The US Lyme community is appalled because only about $20 million is spent annually on TBD research. In the ME/CFS community, the NIH only spends about $5 million annually.
So, if PTLDS and ME/CFS are the same, at least in terms of symptoms, and if the Old Lyme Guard has its way and gets the world to believe PTLDS describes FORMER Lyme patients who no longer are infected, then other than potentially being able to identify the trigger mechanism, how will we be any different than ME/CFS sufferers, and the battles they fight, and their outcomes - how will ours be any different, if in fact they are?
This is in great measure why I follow the struggles of ME/CFS patients.